Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen (Q34063533)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen (English)

1 reference

Europe PubMed Central

30 July 2017

endometrial cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

L Bergman

1

1 reference

Europe PubMed Central

30 July 2017

M L Beelen

2

1 reference

Europe PubMed Central

30 July 2017

M P Gallee

3

1 reference

Europe PubMed Central

30 July 2017

H Hollema

4

1 reference

Europe PubMed Central

30 July 2017

J Benraadt

5

1 reference

Europe PubMed Central

30 July 2017

F E van Leeuwen

6

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

356

1 reference

Europe PubMed Central

30 July 2017

9233

1 reference

Europe PubMed Central

30 July 2017

881-887

1 reference

Europe PubMed Central

30 July 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Second cancers after adjuvant tamoxifen therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial müllerian carcinosarcoma after cessation of tamoxifen therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Random nuclear p53 overexpression pattern in tamoxifen-mediated endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of endometrium treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902677-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02677-5

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34063533&oldid=1962104414"